In contrast, this study revealed that ATP6V1G1 at 9q and PSMA6 at 14q might be potential tRCC tumor suppressors. This evidence concerns the gene PSMA6 and renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.